Details for Patent: 5,462,932
✉ Email this page to a colleague
Summary for Patent: 5,462,932
| Title: | Oral liquid alendronate formulations |
| Abstract: | Disclosed is a therapy protocol for treating and for preventing bone loss in patients who have difficulty in swallowing by administering a liquid formulation of alendronate which can be easily swallowed. Also described are pharmaceutical dosage forms of a syrup, aqueous solution, a solution formed from a reconstituted powder, of alendronate, for carrying out the therapeutic method. |
| Inventor(s): | Brenner; Gerald S. (Norristown, PA), Katdare; Ashok V. (Norristown, PA), Pretzer; Denise (Chesterfield, MO), Whiteford; Donna T. (Brooklyn, NY) |
| Assignee: | Merck & Co., Inc. (Rahway, NJ) |
| Application Number: | 08/245,289 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Formulation; Compound; |
Drugs Protected by US Patent 5,462,932
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,462,932
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Austria | 222495 | ⤷ Try a Trial | |||
| Australia | 2901095 | ⤷ Try a Trial | |||
| Australia | 691634 | ⤷ Try a Trial | |||
| Canada | 2190148 | ⤷ Try a Trial | |||
| China | 1079672 | ⤷ Try a Trial | |||
| China | 1148341 | ⤷ Try a Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
